Bone marrow depression caused by cancer chemotherapy.
スポンサーリンク
概要
- 論文の詳細を見る
The continuous combination chemotherapy of vincristine, methotrexate, peplomycin and mitomycin c (VMPM therapy) was carried out in 9 patients with squamous cell carcinoma of the oral region. During this VMPM therapy, severe a bone marrow depression was observed, so that its clinical aspect was presented.<BR>Side effects due to VMPM therapy were detected in 7 cases (77.8%), and especially in 4 cases, white blood cells (W BC) and platelets began to decrease rapidly about 4 to 5 days after the begining of VMPM therapy. The number of W BC and platelets in these 4 cases were 500-700/mm<SUP>3</SUP> and 7, 000-34, 000/mm<SUP>3</SUP> at their nadir, respectively. A few antibiotics, together with human immunoglobulin in 1 case, were applied to prevent infection, and there was no evidence of infection. As to the thrombocytopenia, the approximate 19-31 units of platelet rich plasma were infused to each case, which resulted in no episode of bleeding.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果